392 related articles for article (PubMed ID: 18751917)
61. [Clinical significance of heat shock proteins. Influence of heat shock proteins on the pathomechanism of selected diseases].
Gryglewski A; Pajdak W; Witkowski K
Przegl Lek; 1994; 51(7):303-7. PubMed ID: 7871204
[TBL] [Abstract][Full Text] [Related]
62. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury.
Vidali M; Stewart SF; Albano E
Trends Mol Med; 2008 Feb; 14(2):63-71. PubMed ID: 18222109
[TBL] [Abstract][Full Text] [Related]
63. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases.
Abdolmaleki F; Kovanen PT; Mardani R; Gheibi-Hayat SM; Bo S; Sahebkar A
Clin Rev Allergy Immunol; 2020 Feb; 58(1):82-91. PubMed ID: 31267470
[TBL] [Abstract][Full Text] [Related]
64. Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus.
Ferreira HB; Pereira AM; Melo T; Paiva A; Domingues MR
J Pharm Biomed Anal; 2019 Sep; 174():386-395. PubMed ID: 31207360
[TBL] [Abstract][Full Text] [Related]
65. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
66. Natural antibodies against phosphorylcholine in cardiovascular disease.
de Faire U; Frostegård J
Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
[TBL] [Abstract][Full Text] [Related]
67. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.
Phillis JW; Horrocks LA; Farooqui AA
Brain Res Rev; 2006 Sep; 52(2):201-43. PubMed ID: 16647138
[TBL] [Abstract][Full Text] [Related]
68. Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases?
Lazzerini PE; Capecchi PL; Selvi E; Lorenzini S; Bisogno S; Galeazzi M; Laghi Pasini F
Lupus; 2007; 16(11):852-62. PubMed ID: 17971357
[TBL] [Abstract][Full Text] [Related]
69. Picrorhiza scrophulariiflora improves accelerated atherosclerosis through inhibition of redox-sensitive inflammation.
Guo ZJ; Hou FF; Liu SX; Tian JW; Zhang WR; Xie D; Zhou ZM; Liu ZQ; Zhang X
Int J Cardiol; 2009 Aug; 136(3):315-24. PubMed ID: 19178960
[TBL] [Abstract][Full Text] [Related]
70. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
Gisondi P; Girolomoni G
Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
[TBL] [Abstract][Full Text] [Related]
71. Bacteriophages in autoimmune disease and other inflammatory conditions.
Riley PA
Med Hypotheses; 2004; 62(4):493-8. PubMed ID: 15050095
[TBL] [Abstract][Full Text] [Related]
72. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
Montecucco F; Mach F
Rheumatology (Oxford); 2009 Jan; 48(1):11-22. PubMed ID: 18927189
[TBL] [Abstract][Full Text] [Related]
73. Role of mast cells in progressive renal diseases.
Holdsworth SR; Summers SA
J Am Soc Nephrol; 2008 Dec; 19(12):2254-61. PubMed ID: 18776124
[TBL] [Abstract][Full Text] [Related]
74. Effects of alcohol-free beer on lipid profile and parameters of oxidative stress and inflammation in elderly women.
Martínez Alvarez JR; Bellés VV; López-Jaén AB; Marín AV; Codoñer-Franch P
Nutrition; 2009 Feb; 25(2):182-7. PubMed ID: 18947976
[TBL] [Abstract][Full Text] [Related]
75. Pathological aspects of lipid peroxidation.
Negre-Salvayre A; Auge N; Ayala V; Basaga H; Boada J; Brenke R; Chapple S; Cohen G; Feher J; Grune T; Lengyel G; Mann GE; Pamplona R; Poli G; Portero-Otin M; Riahi Y; Salvayre R; Sasson S; Serrano J; Shamni O; Siems W; Siow RC; Wiswedel I; Zarkovic K; Zarkovic N
Free Radic Res; 2010 Oct; 44(10):1125-71. PubMed ID: 20836660
[TBL] [Abstract][Full Text] [Related]
76. Protein damage and inflammation in uraemia and dialysis patients.
Galli F
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v20-36. PubMed ID: 17586842
[TBL] [Abstract][Full Text] [Related]
77. Is atherosclerosis a neurogenic phenomenon?
Marwah RS; Doux JD; Lee PY; Yun AJ
Med Hypotheses; 2007; 69(4):884-7. PubMed ID: 17400398
[TBL] [Abstract][Full Text] [Related]
78. Inflammatory mediators involved in the progression of the metabolic syndrome.
Ma K; Jin X; Liang X; Zhao Q; Zhang X
Diabetes Metab Res Rev; 2012 Jul; 28(5):388-94. PubMed ID: 22389088
[TBL] [Abstract][Full Text] [Related]
79. In vivo imaging of autoimmune disease in model systems.
Ahrens ET; Morel PA
Curr Top Dev Biol; 2005; 70():215-38. PubMed ID: 16338343
[TBL] [Abstract][Full Text] [Related]
80. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer.
Rabinovich GA; Liu FT; Hirashima M; Anderson A
Scand J Immunol; 2007; 66(2-3):143-58. PubMed ID: 17635792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
